# Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-response-rate-of-second-line-chemotherapy-for-recurrent-or-refractory-clear/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masashi Takano,Toru Sugiyama,Nobuo Yaegashi,M. Sakuma,Mitsuaki Suzuki,Yosuke Saga,Kazuo Kuzuya,Junzo Kigawa,Muneaki Shimada,Hitoshi Tsuda,Takuya Moriya,Akira Yoshizaki,Toshiyuki Kita,Yoshiaki Kikuchi |
| Citations | 98 |
| DOI | 10.1111/j.1525-1438.2007.01158.x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2170840794 |
| PMID | 18081792 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Toshiyuki Kita](https://scholariq.org/researchers/toshiyuki-kita/)

## Paper journal

- [International Journal of Gynecological Cancer](https://scholariq.org/journals/international-journal-of-gynecological-cancer/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.